CD28-mediated co-stimulation: a quantitative support for TCR signalling.
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [3]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 6×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialThe lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 1×
“CD28-induced activation of AKT upregulates glucose metabolis”
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 7×
“This phosphorylation requires PtdIns(3,4,5)P 3 -activated AKT kinase and it is sensitive to inhibition by pharma cological inhibitors of PI3K(25,45).”
BackgroundInfluentialCD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023 · cited 1×
“This is also indicated by studies showing that CD28 ligation lowers the number of triggered TCRs that are required for a given respons”
Background
Cited by
Items 501–600 of 797
CAR-T Cell Therapy for Prostate Cancer: Current Advances and Future Perspectives
Calabrò, M. L., Ettari, R., Chio, C. D., Luca, F. D., Previti, S., & Zappalà, M. (2025) · Biomedicines · doi:10.3390/biomedicines13102545 · Cited by 11
“Costimulation via CD28 is crucial for enhancing clonal proliferation, survival and differentiation into effector and memory T cells [123,124].”
Ascierto, P. A., Puzanov, I. J., Agarwala, S. S., Bifulco, C. B., Botti, G., Caracò, C., Ciliberto, G., Davies, M. A., Dummer, R., Ferrone, S., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1568-6 · Cited by 8
CD28 engagement inhibits CD73-mediated regulatory activity of CD8+ T cells
Lai, Y., Kuo, L.-C., Lin, B., Lin, H., Lin, C.-Y., Chen, Y., Hsiao, P., Chang, H., Ko, P. C., Chen, H.-C., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02119-9 · Cited by 9
Dong, B., Obermajer, N., Tsuji, T., Matsuzaki, J., Bonura, C. M., Sander, C., Withers, H. G., Long, M. D., Chavel, C. A., Olejniczak, S. H., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0061 · Cited by 9
Kornacker, M., Verneris, M. R., Kornacker, B., Ganten, T. M., Scheffold, C., & Negrin, R. S. (2006) · Cytotherapy · doi:10.1080/14653240500518264 · Cited by 8
Virus Attachment and Replication Are Promoted after Acquisition of Host CD28 and CD152 by HIV‐1
Giguère, J., Diou, J., Madrenas, J., & Tremblay, M. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/444426 · Cited by 8
“However, the roles played by these 2 T cell–specific surface molecules is fundamentally distinct [3].”
BackgroundDavies, M. A., Patel, S., & Kim, K. B. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-424-1_9 · Cited by 8
Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions
Nagaraju, G. P., Nellipudi, H. R., Ganji, C., Kuppala, V., Ganji, S. P., Kumari, S., Farran, B., Srilatha, M., Guenter, R. E., & El‐Rayes, B. F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02705-5 · Cited by 9
“111 T-cell proliferation, cytokine production, and effector differentiation are all fueled by downstream transcriptional programs initiated by this coordinated signaling.”
PATHLOGIC-S: A Scalable Boolean Framework for Modelling Cellular Signalling
Fearnley, L. G., & Nielsen, L. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041977 · Cited by 8
“It has been experimentally demonstrated that CD28 is not required for Jnk activation in activated T-cells [24,25], and CD28 is in fact inactive in our solution.”
Canichella, M., Molica, M., Mazzone, C., & de Fabritiis, P. (2023) · Cancers · doi:10.3390/cancers16010042 · Cited by 7
Targeting Co-Stimulatory Pathways in Gene Therapy
Huang, X., & Yang, Y. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00202 · Cited by 7
“Recent studies have reported chromatin structural changes within minutes following T cell activation, and induction of DNA demethylation of IL-2 gene as early as 20 min after TCR/CD28 stimulation, suggesting a role for CD28 signaling in these early nuclear events, which are critical to the ensuing processes of cell pr…”
BackgroundManagement of checkpoint inhibitor-associated renal toxicities
Vanoverbeke, L., & Sprangers, B. (2017) · Expert Review of Quality of Life in Cancer Care · doi:10.1080/23809000.2017.1369045 · Cited by 7
“Many co-stimulatory molecules have been described which can be both activating or inhibiting [9,10].”
BackgroundAdoptive tumor infiltrating lymphocyte transfer as personalized immunotherapy
Díaz-Cano, I., Paz-Ares, L. G., & Otano, I. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.003 · Cited by 8
Quenum, A., Santharam, M. A., Ramanathan, S., & Ilangumaran, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214122 · Cited by 7
Mechanisms of Allergic Contact Dermatitis
Rustemeyer, T., van Hoogstraten, I. M. W., Blomberg, B. M. E. V., & Scheper, R. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-02035-3_14 · Cited by 7
Wu, X., Gowda, K., & Gowda, D. C. (2010) · Experimental Parasitology · doi:10.1016/j.exppara.2010.07.016 · Cited by 7
“Since the expression of costimulatory molecules is essential for the activation of T cells (Acuto and Michel, 2003; Sharpe, 2009), our results suggest that initiation of adaptive immunity occurs at very early stages of infection, even when the pathogen loads are low.”
BackgroundNishikawa, T., Takeuchi, A., Machiyama, H., Wakamatsu, E., Nishijima, H., Furuhata, M., Toyota, H., Nishi, W., Matsushima, R., Yoshida, Y., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08906-y · Cited by 6
“Therepre-sentativeT-cellcostimulatoryreceptorCD28bindstoCD80andCD86 expressedonAPCs,andCD28-mediatedsignalingisindispensableforcell proliferation,survival,metabolism,andcytokineproduction 12 – 14 .”
Reactivating exhausted tumor-infiltrating T cells by a bispecific DC-T cell engager in mice
Zhang, X., Gao, Y., Hu, W., Liang, Y., Yin, X., Shi, X., Li, H., Liao, H., Guo, J., Yu, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70876-4 · Cited by 8
Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury
Staller, D. W., Bennett, R. G., & Mahato, R. I. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2369590 · Cited by 6
“The simultaneous stimulation of the TCR and CD28 has been previously shown to prevent T cell death while simultaneously promoting clonal expansion and IL-2 production in vivo [125].”
Svedova, J., Tsurutani, N., Liu, W., Khanna, K. M., & Vella, A. T. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600113 · Cited by 7
Kunkl, M., Amormino, C., Spallotta, F., Caristi, S., Fiorillo, M. T., Paiardini, A., Kaempfer, R. O. R., & Tuosto, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1170821 · Cited by 8
“CD28-dependent signals, thus leading to optimal T cell activation (24, 51, 53) and inflammatory responses (20, 21, 23, 26), even in the absence of MHC class II co-engagement (27).”
BackgroundTethered Signaling in Inhibitory Immune Receptors
Pérez-Ferreros, P., Gaus, K., & Goyette, J. (2019) · Frontiers in Physics · doi:10.3389/fphy.2018.00158 · Cited by 6
“These phosphorylated tyrosines recruit cytosolic mediators, such as phosphoinositide 3-kinase and Grb2, thereby augmenting T cell activation [21].”
BackgroundFurlong, S. J., Coombs, M. R. P., & Hoskin, D. W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7242 · Cited by 6
“It was hypothesized that a greater number of Thy-1 molecules were crosslinked by mAb compared with TcR β , as excess mAbs were used, and it has been reported that T cells express ~200,000 Thy-1 molecules/cell and only ~2,000 TcR molecules/cell (31,32).”
Charab, W., Rosenberger, M. G., Shivram, H., Mirazee, J. M., Donkor, M. K., Shekhar, S., Gjuka, D., Khoo, K. H. L., Kim, J. E., Iyer, V. R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713704 · Cited by 8
“via CD28) which activates NF-kb via the PI3K-AKT-PKCq-CARMA1 axis (73, 74).”
BackgroundWon, H. Y., Min, H. J., Lee, W. H., Kim, S. G., & Hwang, E. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.079 · Cited by 6
“TCR stimulation selectively induces proliferation and differentiation of CD4+ or CD8+ T cells through the activation of receptor-associated signaling molecules such as ZAP-70, LAT, PLC-c1, PKC, and GRB2/SOS, and following an increase in intracellular calcium influx [16,17].”
BackgroundOX40:OX40L Axis: Emerging Targets for Immunotherapy of Human Disease
Salek‐Ardakani, S., Song, A., Humphreys, I. R., & Croft, M. (2006) · Current Immunology Reviews · doi:10.2174/157339506775471884 · Cited by 6
“The Ig superfamily member CD28, a receptor for both B7-1 (CD80) and B7-2 (CD86), is considered to be the primary costimulatory receptor that controls initial division, and survival signals to T cells and also controls their ability to secrete effector proteins such as cytokines [2].”
BackgroundRegulation of Immune Cell Functions through Nectin and Nectin-Like Receptors
Martinet, L., & Smyth, M. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.02010-5 · Cited by 6
CD8 T Cell Memory to Pathogens
Kalia, V., Ahmed, R., & Sarkar, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14012-3 · Cited by 6
Valitutti, S., & Espagnolle, N. (2006) · Wiley eBooks · doi:10.1038/npg.els.0004027 · Cited by 6
Moltu, K. (2013) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000264 · Cited by 5
“TCR and CD28 signaling cascades must occur concurrently and in close proximity to ensure maximal T cell activation [5].”
BackgroundZoghi, S., Masoumi, F., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00005-0 · Cited by 8
Cancer Immunotherapy: Challenges and Advancements in CAR T Cell Technology
Yenchitsomanus, P. (2024) · Siriraj Medical Journal/San Sirirat · doi:10.33192/smj.v76i5.268031 · Cited by 5
Lü, J., Chen, G., Sorokina, A., Nguyen, T. B. V., Wallace, T., Nguyen, C., Dunn, C., Wang, S., Ellis, S., Shi, G., et al. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00307-7 · Cited by 5
“The activation-induced proliferation of CD8+ T cells requires the engagement of the TCR with peptide presented by MHC class I and co-stimulatory receptors such as CD28, CD27, and others [20, 21].”
BackgroundWitsenburg, J. J., Glauner, H., Müller, J. P., Groenewoud, J. M. M., Roth, G. D., Böhmer, F.-D., Adjobo-Hermans, M. J. W., & Brock, R. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079277 · Cited by 5
“for full T cell activation [18,19,20].”
Bacterial lectin BambL acts as a B cell superantigen
Frensch, M., Jäger, C., Müller, P. F., Tadić, A., Wilhelm, I., Wehrum, S., Diedrich, B., Fischer, B., Meléndez, A. V., Dengjel, J., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04009-z · Cited by 5
Imaging Membrane Order and Dynamic Interactions in Living Cells with a DNA Zipper Probe
Bagheri, Y., Ali, A. A., Keshri, P., Chambers, J. J., Gershenson, A., & You, M. (2021) · Angewandte Chemie · doi:10.1002/ange.202112033 · Cited by 5
Madrid-Miller, A., Chávez-Sanchéz, L., Careaga-Reyna, G., Borrayo–Sánchez, G., Chávez-Rueda, A. K., Montoya-Guerrero, S. A., Abundes-Velasco, A., Ledesma-Velasco, M., Legorreta-Haquet, M. V., & Blanco-Favela, F. A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-669 · Cited by 5
“It is likely that the secretion of activated TGF β1 leads to an increase in the production of extracellular matrix and to plaque progression and disruption [25,29-33].”
BackgroundUrrea, F., Ortíz-Quintero, B., Sánchez‐García, F. J., Blanco-Favela, F. A., Garfias, Y., Lascuraín, R., & Zenteno, E. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.221.271 · Cited by 5
“Some experiments were carried out in the presence of an anti-CD28 antibody (1.0 µg/mL).”
BackgroundInfluentialKumar, S., Gautam, P. K., Tomar, M. S., & Acharya, A. (2015) · Immunologic Research · doi:10.1007/s12026-015-8752-z · Cited by 5
“As CD28 was found to be an ultimate costimulatory molecule, required for the activation, proliferation, differentiation and induction of effector function in T cells [33] such as production of various lymphokines [18], we measured IL-2 and IFN-c, important Th1 cytokines secreted by T cells, with the help of ELISA.”
BackgroundStimulus Dependence of the Action of Small‐Molecule Inhibitors in the CD3/CD28 Signalling Network
Köhler, K., Ganser, A., André, T., Roth, G. D., Große‐Hovest, L., Jung, G., & Brock, R. E. (2008) · ChemMedChem · doi:10.1002/cmdc.200800134 · Cited by 4
Felts, S. J., Keulen, V. P. V., Scheid, A. D., Allen, K. S., Bradshaw, R. K., Jen, J., Peikert, T., Middha, S., Zhang, Y., Block, M. S., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1745-x · Cited by 4
“, Th1, Th2, Th17, Treg [20, 21]) and other less frequent cell types such as CD4+ macrophages [22] should be captured in this assay.”
InfluentialEngagement of CD45 alters early signaling events in human T cells co-stimulated through TCR + CD28
Bhatta, A., Chan, M. A., & Benedict, S. H. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104130 · Cited by 4
Aoki, S. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00072 · Cited by 4
“29,30) In the absence of the co-stimulatory signal 2, T cells enter an anergic state, where antigen-specific T cells are unable to respond to an immunogenic stimulus.”
Moares, N., Gonzalez‐Garcia, P., Yi‐He, W., Muñoz-Miranda, J. P., Gabucio, A., Luna‐Espejo, R., Ocaña‐Cuesta, J., Fernández-Cisnal, R., Fernandez-Ponce, C. M., & Garcia-Cozar, F. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1613222 · Cited by 4
“It is described that CD28 activation is mediated by the binding to its ligands, CD80 and CD86, which eventually leads to the induction of NF k B-dependent expression of the anti-apoptotic protein BCL-XL, which is a key survival mechanism in T-cells (69 – 71).”
CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
da Silva, M. V., Machado, J. R., Rocha, L. P., Castellano, L. R. C., dos Reis, M. A., & Corrêa, R. R. M. (2012) · Journal of Transplantation · doi:10.1155/2012/203780 · Cited by 4
“Nevertheless, the binding of the same molecules to CTLA-4 induces the expression of proapoptotic genes as well as the production of immunoregulatory cytokines, and it also favors restoration of homeostasis and induction of peripheral tolerance, both required for the prevention of autoimmune phenomena and for the survi…”
BackgroundSong, B., Aoki, S., Liu, C., Susukida, T., Kuwahara, S., & Ito, K. (2021) · Toxicology · doi:10.1016/j.tox.2021.152971 · Cited by 5
Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BB
Linhares, A. D. S., Sharma, S., Steinberger, P., & Leitner, J. M. (2024) · iScience · doi:10.1016/j.isci.2024.109267 · Cited by 4
“2,33 In line with that we found that genes such as IL2RA, CD69, EGR1, or EGR2, which are strongly induced during TCR activation were further induced upon engagement of mICOS::CD28 although this augmentation did not reach statistical significance in our dataset.”
BackgroundHuang, C., Chen, L.-H., Huang, H.-Y., Kao, F.-S., Lee, Y., Selvaraju, M., Sun, C., & Chen, H. M. (2015) · RSC Advances · doi:10.1039/c5ra06095h · Cited by 4
García‐Espinoza, J. A., Muñóz-Valle, J. F., García‐Chagollán, M., Hernández‐Bello, J., Palafox‐Sánchez, C. A., López‐Villalobos, E. F., Sánchez‐Zuno, G. A., Martínez-Bonilla, G., Cerpa‐Cruz, S., Carrillo‐Ballesteros, F. J., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44020053 · Cited by 4
“In this line, the expression of co-stimulatory proteins is necessary for the proper functioning of the immune system [8].”
BackgroundCbl-b inhibited CD4+ T cell activation by regulating the expression of miR-99a/miR-125b
Wu, M., Gao, X., Tang, Y., Wu, W., Zhou, J., Shao, Y., Hao, C., Yang, Y., & Zhang, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109677 · Cited by 5
NKG2D receptor signaling shapes T cell thymic education
Pérez, C., Plaza-Rojas, L., Boucher, J. C., Nagy, M. Z., Kostenko, E., Prajapati, K., Burke, B., Reyes, M. D., Austin, A. L., Zhang, S., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad130 · Cited by 5
Harnessing Stem Cell-Like Memory T Cells for Adoptive Cell Transfer Therapy of Cancer
Lugli, E., & Gattinoni, L. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-21167-1_8 · Cited by 8
Dynamic Regulation of T Cell Activation by Coupled Feedforward Loops
Buri, G., Zelleke, G. M., & Ndifon, W. O. (2021) · Mathematics of planet earth · doi:10.1007/978-3-030-50826-5_9 · Cited by 5
Hwang, J.-R., Nguyen, C. T. N., Ko, G.-H., Kang, J., Byeon, Y., Park, S., Chang, R., Jung, D., Jeon, M. Y., Sung, Y. H., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02385-7 · Cited by 3
CD28 costimulation is organized by signaling condensates and counteracted by PD-1
Chen, H., Wu, S., Zhang, Y., Hu, W., Lou, C., Chen, W., & Lou, J. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2612742123 · Cited by 2
[Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer].
Wang, S., & Li, J. (2016) · PubMed Central · doi:10.3779/j.issn.1009-3419.2016.10.09 · Cited by 3
Antagonism of CD28 blocks allergic responses in the ovalbumin-induced asthmatic model mice
Kuo, C.-Y., Huang, C.-Y., Chen, H. M., Chen, L., & Kuo, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114071 · Cited by 3
Emergence of chronic Lyme arthritis: Putting the breaks on CD28 costimulation
Iliopoulou, B. P., & Huber, B. T. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802391459 · Cited by 3
“It has been proposed that if indeed the CD28 molecule provides a quantitative support for T cell receptor (TCR) signaling, high antigen concentration or continuous presence of pathogen antigens may lead to the induction of a CD28independent activation of an immune response.((25,26,46)) We find an example of this scena…”
BackgroundImmune Responses to Viral Infection
Streeck, H., Suscovich, T. J., & Alter, G. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch16 · Cited by 3
Silveira, D. A., Ribeiro, F. M., Simão, É. M., de Mattos, V. L. D., & de Góes, E. G. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1857454 · Cited by 3
Development of Regulatory T Cells in the Thymus
Kitagawa, Y., & Sakaguchi, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.04017-0 · Cited by 3
The Role of CD80 and CD86 In Macrophage Activation and its Regulation Following LPS Stimulation
Woldai, S. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-6487 · Cited by 3
“CD14 recruits an accessory protein MD2, which in turn binds to TLR-4 expressed on APCs (73).”
BackgroundInfluentialProtocol for assessing T cell receptor-mediated human T cell cytotoxicity
Marks, K. E., Adejoorin, I., Sowerby, J. M., & Rao, D. A. (2025) · STAR Protocols · doi:10.1016/j.xpro.2024.103541 · Cited by 2
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency
Bucher, P., Brückner, N., Kortendieck, J., Grimm, M., Schleicher, J., Bartels, K., Hardy, S., Rausch, M., Wurzer, H., Thiemann, M., et al. (2026) · Nature Cancer · doi:10.1038/s43018-025-01099-7 · Cited by 5
Ran, R., & Brubaker, D. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1715827 · Cited by 3
“However, whether CD28 effectively helps the activation of most intraepithelial gd T cells, or generally speaking, the V d 1 subset, which has stronger cytotoxicity (88), tissue residency (89), and tumor in fi ltration (90 – 92), remains unclear.”
InfluentialLi, J., Jia, Z., Li, D., Hu, Z., Ding, Y., Zhang, S., Tuo, S., Yang, Z., Fu, H., Wang, L., et al. (2026) · Advanced Science · doi:10.1002/advs.202520963 · Cited by 2
“Under normal activation conditions (Figure 5G ), CD28 signaling promotes T-cell survival and proliferation through coordinated activation of the PLC γ -IP 3 -Ca 2 + axis [ 55 ]. and the PI3K-PDK1-Akt pathway [ 56, 57 ], leading to IL-2 production and maintenance of metabolic homeostasis.”
Sahu, V. K., Das, P., Choudhury, S. R., & Karmakar, S. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189592 · Cited by 2
Ambient temperature regulates CD4+ T cell tonic T cell receptor signaling and responsiveness
Sawada, K., Eom, J., Mahoney-Sutherland, B. A., Stankiewicz, T. E., Oates, J. R., Giles, D. A., Alarcon, P. C., Damen, M. S. M. A., Cannata, A., Hargis, J., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115801 · Cited by 2
“In addition to the direct activation of TCR by MHCII, antigen-presenting cells utilize secondary signals (co-stimulatory molecules CD80 and CD86 that serve as ligands of CD28 expressed on T cells) 69 for enhanced T cell activation.”
Verleng, L. J., Busselaar, J., Mensink, M., Schrama, E., Kapsenberg, H., van der Keur, C., Lei, X., Eikmans, M., Xiao, Y., de Kivit, S., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1865340 · Cited by 2
Matsueda, H., Kawano, M., Takagi, R., Koshimizu, K., & Matsushita, S. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12427 · Cited by 2
Chatila, T. A., & Palma, R. D. (2017) · European Journal of Immunology · doi:10.1002/eji.201747359 · Cited by 2
Gouveia, A. C. C., Lott, B., Saúde, F. E. C. A. C. E., Semedo, F., Inácio, F., de Freitas, G. R. M., Plácido, G., Consultancy, 4. H., Mota‐Filipe, H., Gonçalves, J., et al. (2022) · Conselho Federal de Farmácia eBooks · doi:10.14450/profar.9786587599229 · Cited by 8
Wang, Z., Zhang, Y., Wu, L., Chen, J., Xie, S., He, J., Zhang, Q., Chen, H., Chen, F., Liu, Y., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202307656 · Cited by 5
Challenges and future perspectives for high-throughput chimeric antigen receptor T cell discovery
Butler, S. E., & Ackerman, M. E. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103216 · Cited by 2
Gao, H., Qu, L., Li, M., Guan, X., Zhang, S., Deng, X., Wang, J., & Xing, F. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139829 · Cited by 2
Jordan, S. C., & Toyoda, M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3993-8.00041-6 · Cited by 2
CD4+CD28null T cells in acute coronary syndrome: lower with ST-elevation myocardial infarction
Sayed, N. M., Abdel-Rahman, S. M., Esmat, I., & Nammas, W. (2015) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2015.1088167 · Cited by 2
Vaccine Therapy and Immunotherapy for Pancreatic Cancer
Zheng, L., & Jaffee, E. M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_53 · Cited by 2
Jeras, M., Bricl, I., Zorec, R., & Švajger, U. (2010) · BioMed Research International · doi:10.1155/2010/705215 · Cited by 3
“The delayed appearance of these costimulatory receptors on activated CD8+ T cells supports the hypotheses that they are involved in sustaining the ongoing cellular immune response as well as supporting the survival of the newly induced CTLs [49].”
BackgroundAntigen-Specific Signal Transduction
Rosenspire, A. J., & Stemmer, P. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.01999-1 · Cited by 3
The Role of Lymphocytes in the Pathogenesis of Atherosclerosis: Focus on CD4+ T Cell Subsets
Dumitriu, I. E., & Kaski, J. C. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4429-8_2 · Cited by 2
Protein Arginine Methylation: A New Frontier in T Cell Signal Transduction
Schurter, B. T., Blanchet, F. P., & Acuto, O. (2007) · Springer eBooks · doi:10.1007/0-387-34132-3_14 · Cited by 2
Self-citationChimeric antigen receptor T cells for the treatment of lymphoma
Purev, E., & Fry, T. J. (2017) · Annals of Lymphoma · doi:10.21037/aol.2017.10.02 · Cited by 2
“Both CD28 and 4-1BB costimulation induce IL-2 production by T cells (25-27), enhance survival of activated T cells (28,29), and support cytotoxic activity of T cells (30-33).”
BackgroundJavadrashid, D., Baghbanzadeh, A., Hemmat, N., Hajiasgharzadeh, K., Nourbakhsh, N. S., Lotfi, Z., & Baradaran, B. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.02.009 · Cited by 2
Immune Tolerance in the Periphery
Mak, T. W., & SAUNDERS, M. (2006) · Elsevier eBooks · doi:10.1016/b978-012088451-3.50018-1 · Cited by 2
Peripheral Tolerance of T Cells in the Mouse
Heissmeyer, V., Tanasă, B., & RAO, A. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50088-1 · Cited by 2
Posttranscriptional Events Orchestrate Immune Homeostasis of CD8+ T Cells
Heeren, J. J. F. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3754-8_4 · Cited by 1
Advances in CAR optimization strategies based on CD28
Li, S., Zhou, Y., Wang, H., Qu, G., Zhao, X., Wang, X., Hou, R., Guan, Z., Liu, D., Zheng, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1548772 · Cited by 3
Hassaballa, M. A., Hanna, M. O. F., Radwan, A. M., EL-Adawy, N. M., Helmy, A. K., Fayad, T., El‐Ansary, M., & Saadi, G. E. (2025) · Transplant Immunology · doi:10.1016/j.trim.2025.102268 · Cited by 2
Mechanotransduction through T cell receptors: consensus, controversies and future outlooks
Travaglino, S., Jeon, Y., Kim, Y., Zhu, C., & Choi, H.-K. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01639-w · Cited by 7
“This model accounts for why antibody-induced signaling requires immobilization and suggests that native ligands such as B7-1/B7-2 may trigger CD28 in a KS-like manner.”
InfluentialBennstein, S. B., Reiß, J., Raba, K., Pham, T. X. U., Paulusch, S., Domenico, E. D., Niehues, T., Fischer, J., Kögler, G., Beyer, M. D., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117000 · Cited by 1
Staal, M. D., Wang, Z., Bosma, D. M. T., Busselaar, J., Schrama, E., de Vries, E., Xiao, Y., & Borst, J. G. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01689-7 · Cited by 1
“6B), the ligands of T-cell co-stimulatory receptor CD28 [34, 36]. cDC1s also had similar increased expression of CD40 (Fig.”
T cell lymphomas: cancers of aberrant immune synapse signalling
Tauber, P. A., & Ruland, J. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01283-5 · Cited by 1
Guerreiro, M. C., Pinto, I. S., Farinha, D., & Faneca, H. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126848 · Cited by 1
Environmental regulation of mucosal-associated invariant T cells: Adding food for thought
Ryan, E. K., Sinclair, L. V., & Hogan, A. E. (2026) · Science Signaling · doi:10.1126/scisignal.aec6992 · Cited by 1
Co-Receptors in the Positive and Negative Regulation of T-Cell Immunity
Schneider, H., & Rudd, C. E. (2008) · Springer eBooks · doi:10.1007/978-4-431-73884-8_8 · Cited by 1
Antigen-Specific Signal Transduction
Rosenspire, A. J., & Stemmer, P. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00619-9 · Cited by 3
The T Cell Response to Transplantation Antigens
Mandelbrot, D. A., Burrell, B. E., Sayegh, M. H., & Heeger, P. S. (2010) · Wiley eBooks · doi:10.1002/9781444355628.ch3 · Cited by 1
Neue Aspekte der medikamentösen Therapie des malignen Pleuramesothelioms
Kurz, S., & Grohé, C. (2014) · Pneumologie · doi:10.1055/s-0034-1365025 · Cited by 1
Pachéco, Y., Calender, A., Valeyre, D., & Lebecque, S. (2013) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2013.06.003 · Cited by 1
Metadata
- Authors
- Acuto, O., & Michel, F.
- Affiliations
- Institut Pasteur (FR)
- Corresponding author
- Acuto, Oreste
- ORCID
- Michel, Frédérique
- Venue
- Nature Reviews Immunology
- Published
- 2003-12
- Volume
- 3
- Issue
- 12
- Pages
- 939-951
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2055248228
- Cited by
- 775
- References
- 157
- Citations by year
- 2026: 26 · 2025: 32 · 2024: 31 · 2023: 23 · 2022: 42 · 2021: 33 · 2020: 32 · 2019: 25 · 2018: 38 · 2017: 43 · 2016: 42 · 2015: 35 · 2014: 29 · 2013: 37 · 2012: 33
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, costimulation, T cell receptor signaling, T cell activation, naive T cells, clonal expansion, costimulatory receptors, signal amplification
- MeSH terms
- Animals, Carrier Proteins, Cell Cycle, Humans, Lymphocyte Activation, Membrane Proteins, Phosphoproteins, T-Lymphocytes, Signal Transduction, CD28 Antigens, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.